Bayer launches endometriosis awareness campaign; Leo introduces psoriasis treatment Otrexup; Sanofi rolls out online midwife community;

> Bayer HealthCare teamed up with Latifah Hospital in the United Arab Emirates on an endometriosis awareness campaign. Report

> Leo Pharma rolled out its new psoriasis drug Otrexup, a subcutaneous formula of methotrexate developed with Antares Pharma, in the U.S. Release

> Sanofi ($SNY) launches a new online community, Connecting Midwives, in cooperation with the International Confederation of Midwives; it follows up on the company's Connecting Nurses site. Report

> The healthcare agency Draftfcb Healthcare changed its name to FCB Health and bought the U.K. healthcare agency Halesway. Report

> Bayer Canada won approval for the new pulmonary arterial hypertension treatment, Adempas, from Health Canada. Report

> Pivotal Therapeutics recruited James Connolly, a former Wyeth executive, to serve on its board and advise the company on commercialization strategies. Report

> Teva Pharmaceutical Industries ($TEVA) rolled out its version of Roche's ($RHHBY) cancer treatment Xeloda in the U.S. Release

And Finally... How did Merck ($MRK) roll out a digital marketing strategy in the virgin territory of Indonesia? Report

Suggested Articles

Cardiac risks associated with roxadustat are comparable to placebo in nondialysis patients and to Amgen's standard, Epogen, in those on dialysis.

Pfizer and Merck KGaA's immuno-oncology agent Bavencio failed another gastric cancer study, this time as a maintenance treatment after chemotherapy.

A jury ordered Biogen to pay nearly $6 million to a former sales manager who reported a colleague's misconduct and got fired a few months later.